Agomab Therapeutics NV (AGMB)
Market Closed
27 Jul, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary $
12. 51
0
0%
$
616.09M Market Cap
- P/E Ratio
- Div Yield
33,102 Volume
- Eps
$ 12.51
Previous Close Investors:
Want to track AGMB and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Agomab Therapeutics NV (AGMB) Statistics
Valuation metrics
Market Cap 616.09M
Enterprise value 456.4M
Trailing P/E (ttm) -8.94
Forward P/E -
PEG ratio -0.09
Price/Sales (ttm) -
Price/Book (mrq) 4.09
Enterprise Value/Revenue -
Enterprise Value/EBITDA -7.33
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 62.75K
Average volume (90 days) 89.93K
Price summary
52-Week low 8.75
52-Week high 17.82
Beta -
50-Day moving average 11.26
200-Day moving average 12.49
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.39%
Return on equity -0.46%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.23
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 2.39
Total debt (mrq) -
Total Debt/Equity (mrq) 0.01
Current ratio (mrq) 6.52%
Book value per share (mrq) 2.69
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
